Kim, K., Li, J., Barazia, A., Tseng, A., Youn, S.-W., Abbadessa, G., Yu, Y., Schwartz, B., Andrews, R. K., Gordeuk, V. R. and Cho, J. (2017) “ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease”, Haematologica. Pavia, Italy, 102(2), pp. 246-259. doi: 10.3324/haematol.2016.151159.